Novartis AG (LON:0K9E)
London · Delayed Price · Currency is GBP · Price in USD 130.59
+0.76 (0.59%)
At close: Nov 26, 2025
Novartis AG Market Cap
Novartis AG has a market cap or net worth of 188.41 billion as of November 28, 2025. Its market cap has increased by 14.74% in one year.
Market Cap
188.41B
Enterprise Value
205.47B
Revenue
41.94B
Ranking
n/a
PE Ratio
17.60
Stock Price
130.59
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 77.31B to 188.41B, an increase of 143.70%. That is a compound annual growth rate of 3.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 188.41B | 20.59% |
| Dec 30, 2024 | 156.24B | -3.94% |
| Dec 29, 2023 | 162.64B | 0.78% |
| Dec 30, 2022 | 161.38B | 10.87% |
| Dec 30, 2021 | 145.56B | -8.09% |
| Dec 30, 2020 | 158.37B | -3.22% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.70B |
| HSBC Holdings | 182.88B |
| Shell | 158.39B |
| Unilever | 113.13B |
| British American Tobacco p.l.c. | 94.40B |
| Rio Tinto Group | 91.35B |
| Rolls-Royce Holdings | 88.66B |
| GSK plc | 72.40B |